Ròbert Póka

2.2k total citations
92 papers, 818 citations indexed

About

Ròbert Póka is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Ròbert Póka has authored 92 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Obstetrics and Gynecology, 26 papers in Reproductive Medicine and 23 papers in Oncology. Recurrent topics in Ròbert Póka's work include Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (17 papers) and Cervical Cancer and HPV Research (12 papers). Ròbert Póka is often cited by papers focused on Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (17 papers) and Cervical Cancer and HPV Research (12 papers). Ròbert Póka collaborates with scholars based in Hungary, United States and Spain. Ròbert Póka's co-authors include Bálint Nagy, Beáta Soltész, Rudolf Lampé, András Penyige, Éva Márton, Melinda Szilágyi, Zsolt Török, Zoltán Hernádi, Sándor Szűcs and Péter Takács and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

Ròbert Póka

83 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ròbert Póka Hungary	16	245	227	181	139	118	92	818
Mohamad Nasir Shafiee Malaysia	17	202 0.8×	174 0.8×	105 0.6×	268 1.9×	118 1.0×	57	720
Iztok Takač Slovenia	18	270 1.1×	200 0.9×	126 0.7×	175 1.3×	35 0.3×	101	881
Μenelaos Zafrakas Greece	19	298 1.2×	325 1.4×	86 0.5×	237 1.7×	174 1.5×	73	1.1k
Rafał Watrowski Germany	15	140 0.6×	127 0.6×	86 0.5×	163 1.2×	67 0.6×	56	616
Joshua P. Kesterson United States	18	225 0.9×	190 0.8×	94 0.5×	218 1.6×	64 0.5×	60	779
Thomas W. Jobling Australia	18	293 1.2×	214 0.9×	79 0.4×	303 2.2×	112 0.9×	40	929
Ruifang An China	15	103 0.4×	175 0.8×	87 0.5×	120 0.9×	99 0.8×	58	628
Andrew Menzin United States	16	323 1.3×	210 0.9×	184 1.0×	303 2.2×	54 0.5×	42	870
Haldun Güner Türkiye	15	251 1.0×	132 0.6×	71 0.4×	258 1.9×	82 0.7×	55	664
Lindsay M. Kuroki United States	16	224 0.9×	358 1.6×	222 1.2×	269 1.9×	147 1.2×	81	1.3k

Countries citing papers authored by Ròbert Póka

Since Specialization

Citations

This map shows the geographic impact of Ròbert Póka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ròbert Póka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ròbert Póka more than expected).

Fields of papers citing papers by Ròbert Póka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ròbert Póka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ròbert Póka. The network helps show where Ròbert Póka may publish in the future.

Co-authorship network of co-authors of Ròbert Póka

This figure shows the co-authorship network connecting the top 25 collaborators of Ròbert Póka. A scholar is included among the top collaborators of Ròbert Póka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ròbert Póka. Ròbert Póka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chan, John K., June‐Yong Lee, Mariana Scaranti, et al.. (2025). LBA45 ROSELLA (GOG3073, ENGOTov72, APGOT-OV10): Relacorilant + nab-paclitaxel in the subgroup of patients with platinum-resistant ovarian cancer (PROC) previously exposed to a PARP inhibitor. Annals of Oncology. 36. S1588–S1589.

Chon, Hye Sook, Michael J. Sundborg, Michael S. Gold, et al.. (2024). Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for endometrial cancer (DUO-E/GOG-3041/ENGOT-EN10): Objective response rate and duration of response by mismatch repair status. Gynecologic Oncology. 190. S61–S62. 2 indexed citations

Márton, Éva, Beáta Soltész, András Penyige, et al.. (2021). Comparative Analysis of Cell-Free miR-205-5p, let-7f-5p, and miR-483-5p Expression in Ovarian Cell Cultures and Plasma Samples of Patients with Ovarian Cancer. Applied Sciences. 11(4). 1735–1735. 3 indexed citations

Póka, Ròbert, et al.. (2021). Clinical Impact of Preoperative Magnetic Resonance Imaging in the Evaluation of Myometrial Infiltration and Lymph-Node Metastases in Stage I Endometrial Cancer. Pathology & Oncology Research. 27. 611088–611088. 7 indexed citations

Ledermann, Jonathan A., Bogdan Żurawski, Francesco Raspagliesi, et al.. (2021). Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study. ESMO Open. 7(1). 100311–100311. 14 indexed citations

Póka, Ròbert, et al.. (2020). Nutritional assessment among patients withcervical cancer and controls. European Journal of Gynaecological Oncology. 41(1). 23–23.

Dvorská, Dana, Dušan Braný, Bálint Nagy, et al.. (2019). Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples. International Journal of Molecular Sciences. 20(17). 4119–4119. 26 indexed citations

Penyige, András, Éva Márton, Beáta Soltész, et al.. (2019). Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients. International Journal of Molecular Sciences. 20(18). 4533–4533. 28 indexed citations

Soltész, Beáta, Éva Márton, Melinda Szilágyi, et al.. (2019). Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer. Journal of Biotechnology. 298. 76–81. 64 indexed citations

10.

Márton, Éva, András Penyige, Eszter Anna Janka, et al.. (2019). Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer. Journal of Biotechnology. 297. 58–65. 34 indexed citations

11.

Soltész, Beáta, Éva Márton, Melinda Szilágyi, et al.. (2019). Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients. Journal of Biotechnology. 298. 16–20. 26 indexed citations

12.

Soltész, Beáta, et al.. (2019). Identification of miR-146a and miR-196a-2 single nucleotide polymorphisms at patients with high-grade serous ovarian cancer. Journal of Biotechnology. 297. 54–57. 9 indexed citations

13.

Orosz, László, Zsolt Karányi, Zoltán Tóth, et al.. (2019). Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary. Journal of Biotechnology. 300. 11–19. 4 indexed citations

14.

Tóth, László, Bence Nagy, Gábor Méhes, et al.. (2018). Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites—Correlation of tissue microarray and cytology microarray. Pathology - Research and Practice. 214(7). 978–985. 6 indexed citations

15.

Kristeleit, Rebecca, Domenica Lorusso, Ana Oaknin, et al.. (2017). ARIEL4: An international, randomised phase 3 study of the PARP inhibitor rucaparib vs chemotherapy for the treatment of BRCA-mutated, relapsed, high-grade ovarian cancer. Annals of Oncology. 28. v352–v352. 1 indexed citations

16.

Ledermann, JA, Jalid Sehouli, Bogdan Żurawski, et al.. (2017). A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma. Annals of Oncology. 28. v626–v626. 13 indexed citations

17.

Csorba, Roland, Panagiotis Tsikouras, Rudolf Lampé, & Ròbert Póka. (2012). The sexual abuse of female children in Hungary: 20 years’ experience. Archives of Gynecology and Obstetrics. 286(1). 161–166. 10 indexed citations

18.

Póka, Ròbert, et al.. (2000). The role of preoperative brachytherapy as an adjunct to surgery and postoperative radiotherapy in the treatment of stage I endometrial carcinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology. 92(2). 241–249. 2 indexed citations

19.

Kovács, Judit & Ròbert Póka. (1996). Lipoma of the Uterus. Pathology & Oncology Research. 2(3). 181–183. 4 indexed citations

20.

Póka, Ròbert, et al.. (1993). Comparison of four antiemetic regimens for the treatment of cisplatin‐induced vomiting. International Journal of Gynecology & Obstetrics. 42(1). 19–24. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact